For Healthcare Professionals

For Healthcare Professionals

As Oregon's only Cancer Center designated by the National Cancer Institute, we are committed to partnering with physicians from across the region to care for patients with cancer.

Consultations and referrals

503-494-4567
800-245-6478
Fax: 503-346-6854

Learn more about consultations and referrals



Stay connected with your patient's care at OHSU

Stay Connected - OHSU Connect

If you refer patients to OHSU or OHSU Doernbecher Children's Hospital, you can now track your patient's care in real time with OHSU Connect.

Recent developments in medicine

Clinical trials offer new hope for advanced prostate cancer
Julie N. Graff, M.D.

While immune therapies that work by blocking the PD-1 protein have helped patients with melanoma, liver cancer, non-small cell lung cancer and other malignancies, these agents have not shown meaningful activity against prostate cancer until recently. In the fall of 2016, OHSU researchers led by Julie Graff , M.D., presented evidence that the PD-1 blocker pembrolizumab led to dramatic improvement in some patients.